Advertisement

Beware of Striking Medical Studies

A large-scale statistical analysis shows that medical studies revealing “very large effects” seldom stand up when other researchers try to replicate them.

By | October 25, 2012

Wikimedia, BmramonClinical trials that find very large effects for medical treatments tend not to hold up under further scrutiny, according a study published this week (October 24) in the Journal of the American Medical Association. The authors say the findings should be a reminder to be cautious about exciting early studies.

Analyzing data from 230,000 clinical trials across various disciplines, a team led by Stanford University epidemiologist John Ioannadis found that researchers rarely succeed in replicating study results that claimed a “very large effect.” “The effects largely go away; they become much smaller,” Ioannidis told the Los Angeles Times. “It's likely that most interventions that are effective have modest effects.”

The analysis also revealed that studies reporting outstanding results tended to have used fewer than 100 subjects, so the effects are more likely to be influenced by chance. Moreover, “very large effect” studies usually measure intermediate effects, such as whether statins reduce LDL cholesterol in the blood, rather than more meaningful outcomes like the incidence of disease or death.

The authors suggest that the results should reiterate to patients, physicians, and policymakers that drugs or devices that get glowing reports in small, early-stage trials should be treated with caution—rather than rushed through for approval.

Gordon Guyatt, a clinical epidemiologist at McMaster University in Hamilton, Canada, who was not involved in the study, agreed. People tend to “get excited, and misguidedly so” by these “very large effect” results, he told the LA Times.

(Hat tip to GenomeWeb)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Bio-Rad
Bio-Rad
Advertisement
Life Technologies